Literature DB >> 27641666

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.

Michelle Go1, Jinghong Kou1, Jeong-Eun Lim1, Junling Yang1, Ken-Ichiro Fukuchi2.   

Abstract

Microglia-mediated clearance of amyloid beta-protein (Aβ) via Toll-like receptor 4 (TLR4) signaling may play an important role in the pathogenesis of Alzheimer's disease (AD). However, as the disease progresses, activated microglia appear to become incapable of clearing Aβ deposits. Because repeated exposure to a TLR4 ligand leads to a diminished response of monocytes/macrophages to lipopolysaccharide (LPS) and because aggregated Aβ is a TLR4 ligand, we hypothesize that chronic exposure of microglia to Aβ deposits may induce a state of Toll-like receptor (TLR) signaling dysfunction, leading to decreased Aβ clearance and accelerated disease progression. LPS or phosphate-buffered saline (PBS) was injected into the hippocampus of AD-model (TgAPP/PS1) and wild-type (non-Tg) mice before and after the onset of Aβ deposition, at age 2 and 12 months, respectively. Brain specimens were collected 7 days post-injection and analyzed for microglial activation and Aβ load. While LPS-injected 2-month-old non-Tg mice showed 48-fold and 11-fold greater Iba1 immunoreactivity in the neocortex and hippocampus, respectively, compared with PBS-injected mice, LPS-injected 2-month-old TgAPP/PS1 mice had 61-fold and 13-fold increases in the neocortex and hippocampus, respectively. LPS injection activated microglia more strongly in TgAPP/PS1 mice than in non-Tg mice at 2 months of age. In contrast, at 12 months of age, Iba1 immunoreactivity of microglia was increased 541-fold and 38-fold in the neocortex and hippocampus, respectively, in LPS-injected non-Tg mice and 2.7-fold and 3.3-fold in the neocortex and hippocampus, respectively, in LPS-injected TgAPP/PS1 mice. Surprisingly, LPS injection decreased CD45 immunoreactivity in TgAPP/PS1 mice but increased it in non-Tg mice at 12 months. Although microglia in 12-month-old non-Tg mice showed stronger response to LPS than 2-month-old non-Tg mice, microglia in TgAPP/PS1 mice exhibited diminished immune response to LPS during aging. Our data indicate that microglial TLR4 signaling is altered in an AD mouse model and suggest that altered TLR4 signaling may contribute to Aβ accumulation in the brain.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Animal model; Lipopolysaccharide; Microglia; Toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 27641666      PMCID: PMC5048480          DOI: 10.1016/j.bbrc.2016.09.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology.

Authors:  Henrieta Scholtzova; Richard J Kascsak; Kristyn A Bates; Allal Boutajangout; Daniel J Kerr; Harry C Meeker; Pankaj D Mehta; Daryl S Spinner; Thomas Wisniewski
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

2.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

Review 3.  Microglial priming in neurodegenerative disease.

Authors:  V Hugh Perry; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

Review 4.  Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy.

Authors:  Andrea Broad; David E J Jones; John A Kirby
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

5.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

Authors:  P Cras; M Kawai; S Siedlak; P Mulvihill; P Gambetti; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 6.  Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics.

Authors:  Dave Morgan; Marcia N Gordon; Jun Tan; Donna Wilcock; Amyn M Rojiani
Journal:  J Neuropathol Exp Neurol       Date:  2005-09       Impact factor: 3.685

Review 7.  Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease.

Authors:  Diana M Norden; Megan M Muccigrosso; Jonathan P Godbout
Journal:  Neuropharmacology       Date:  2014-11-13       Impact factor: 5.250

8.  Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.

Authors:  Huazhang An; Hongmei Xu; Minghui Zhang; Jun Zhou; Tao Feng; Cheng Qian; Runzi Qi; Xuetao Cao
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

9.  Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

Authors:  Suzanne E Hickman; Elizabeth K Allison; Joseph El Khoury
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

10.  Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.

Authors:  Jin G Sheng; Susan H Bora; G Xu; David R Borchelt; Donald L Price; Vassilis E Koliatsos
Journal:  Neurobiol Dis       Date:  2003-10       Impact factor: 5.996

View more
  34 in total

1.  The endotoxemia cardiac dysfunction is attenuated by AMPK/mTOR signaling pathway regulating autophagy.

Authors:  Jie Zhang; Peng Zhao; Nanhu Quan; Lin Wang; Xu Chen; Courtney Cates; Thomas Rousselle; Ji Li
Journal:  Biochem Biophys Res Commun       Date:  2017-08-12       Impact factor: 3.575

2.  Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Authors:  Izumi Maezawa; Hai M Nguyen; Jacopo Di Lucente; David Paul Jenkins; Vikrant Singh; Silvia Hilt; Kyoungmi Kim; Srikant Rangaraju; Allan I Levey; Heike Wulff; Lee-Way Jin
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

3.  Minocycline Has Anti-inflammatory Effects and Reduces Cytotoxicity in an Ex Vivo Spinal Cord Slice Culture Model of West Nile Virus Infection.

Authors:  Eamon D Quick; Scott Seitz; Penny Clarke; Kenneth L Tyler
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

4.  Hyperpolarized 13 C magnetic resonance spectroscopy detects toxin-induced neuroinflammation in mice.

Authors:  Lydia M Le Page; Caroline Guglielmetti; Chloé F Najac; Brice Tiret; Myriam M Chaumeil
Journal:  NMR Biomed       Date:  2019-08-22       Impact factor: 4.044

Review 5.  Microglia Phenotypes in Aging and Neurodegenerative Diseases.

Authors:  Menbere Y Wendimu; Shelley B Hooks
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

6.  Role of pattern recognition receptors and the microbiota in neurological disorders.

Authors:  Ciara E Keogh; Kavi M Rude; Mélanie G Gareau
Journal:  J Physiol       Date:  2021-01-13       Impact factor: 5.182

Review 7.  Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

Authors:  Rohit Kumar Tiwari; Afrasim Moin; Syed Mohd Danish Rizvi; Syed Monowar Alam Shahid; Preeti Bajpai
Journal:  Metab Brain Dis       Date:  2021-03-11       Impact factor: 3.584

8.  Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer's Risk Genes Via Suppression of TLR4 Signaling.

Authors:  Junling Yang; Fiona Malone; Michelle Go; Jinghong Kou; Jeong-Eun Lim; Robert C Caughey; Ken-Ichiro Fukuchi
Journal:  J Mol Neurosci       Date:  2020-11-13       Impact factor: 2.866

Review 9.  Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities.

Authors:  Junxuan Lyu; Xiaoyan Jiang; Rehana K Leak; Yejie Shi; Xiaoming Hu; Jun Chen
Journal:  Transl Stroke Res       Date:  2020-10-31       Impact factor: 6.829

Review 10.  β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.

Authors:  Botond Penke; Ferenc Bogár; Lívia Fülöp
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.